Product Program year 2020 Source: CMS Open Payments

3D Revascularization

Device Neurointervention

Open in the dashboard

General payments

$27,344

218 payments

Research payments

$1,649,348

473 payments

Through program year 2020, $27,344 in general payments and $1,649,348 in research payments were reported against 3D Revascularization (Neurointervention).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 Research $207,521 104
2019 General $27,344 218
2019 Research $1,441,827 369

Breakdown

Who paid General payments · program year 2019
  1. Penumbra, Inc. $27,344 218 payments
Top recipients General payments · program year 2019
  1. Ameer Hassan Vascular Neurology · Harlingen, TX $10,989 40% · 2 payments
  2. Ahmed Cheema Neurological Surgery · Milwaukee, WI $1,917 7% · 3 payments
  3. Bryan Vanzandt Diagnostic Radiology · Oklahoma City, OK $1,882 7% · 17 payments
  4. Scott Prater Vascular & Interventional Radiology · Oklahoma City, OK $866 3% · 8 payments
  5. Brian Hailey Vascular & Interventional Radiology · Oklahoma City, OK $860 3% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Vascular Neurology Psychiatry & Neurology $12,357 45% · 14 practitioners
  2. Neurological Surgery $5,155 19% · 31 practitioners
  3. Diagnostic Radiology Radiology $4,586 17% · 27 practitioners
  4. Vascular & Interventional Radiology Radiology $3,344 12% · 18 practitioners
  5. Neuroradiology Radiology $1,068 4% · 10 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Texas $11,673 43% · 12 recipients
  2. Oklahoma $5,073 19% · 7 recipients
  3. Maryland $1,305 5% · 2 recipients
  4. California $1,242 5% · 6 recipients
  5. New York $1,031 4% · 11 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

218 general · 473 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record